The Main Cause Of Cervical Cancer

Cervical cancer is when there are malignant cells present in the cervix; it is developed in the lining of the cervix. A cervix is a narrow opening located at the bottom of the uterus that leads into the vagina. Cervical cancer mostly affects women between the ages of 40 and 55. This cancer can be prevented by screening for precancerous cells, and it can also be cured if it is detected at an early stage. Over the past few decades the number of cervical cancer cases has declined dramatically due to a more widespread screening of the disease. Today, it is estimated that 10,000 new

Cervical cancer is in the lower part of the uterus. Cervical means of or relating to the narrow necklike passage forming the lower end of the uterus the uterus is the is a female's womb. How some people get Cervical cancer is through sexual contact from many partners and also you might get it from smoking a lot , having having many children or having HIV infections

Cervical Cancer Early Detection Program Journal of Women’s Health 20(10):1479-84 doi: 10.1089/jwh.2010.2530. Epub 2011 Jul 20

Center for Disease Control and Prevention (CDC's) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides access to breast and cervical cancer screening to underserved women in all 50 states. NBCCEDP programs use population-based approaches such as public education, patient navigation, and outreach, care coordination to increase screening and reach underserved and uninsured populations. This program provides cervical screening for 21 to 64 year and breast screening for 40 to 64 years. Since this program initiated in 1991 almost 3.7 million women has been screened and 44,885 cases of breast cancer, 2,554 cervical cancers and123, 563 cervical precursor lesions have been detected (Benard et.al , 2011). NBCCEDP use Conceptual Framework supports a collection of strategies to reach uninsured women, including program controlling, screening and diagnostic services. Team members of the NBCCEDP work collaboratively to provide breast and cervical cancer screening, diagnostic evaluation, treatment and referrals. “The program's continued success depends in large part on the complementary efforts of a variety of national partner organizations, as well as on state and community partners” (CDC, 2012). The key success for these two cancer screening programmes

In addition, the article provides an overview of the disease, ways of transmission, vaccinations, emerging issues, and the role of a community health provider especially nurse practitioners (NP). The various databases to obtain the up-to-date information were reviewed in the paper. It states that promoting of HPV vaccination was especially vital because of the fact that 100% of the cases of cervical cancer were attributed to HPV and the vaccine was “the best method for primary prevention (Scott & Batty, 2016).

At first glance, the guidelines seem logical because cervical cancer takes years to develop. However, a majority of the population is not vaccinated against the HPV virus, which is the lead cause of cervical cancer. Until

The symptoms of cervical cancer are not always obvious thus the introduction of NHS cervical screening programme. The aim of the NHS Cervical Screening Programme is prevent the number women who die from cervical cancer each year due to not having early diagnoses. Since the introduction of the programme, a report was done between the NHS Cervical Screening Programme and Trent Cancer Registry it found that “Incidence and mortality rates in England have fallen considerably over the past 20 years. During this period, incidence rates decreased by over a third and mortality rates reduced by 60%. Survival, following a diagnosis of cervical cancer has improved in England since the 1980’s from the 83% to 88%”. (NHS, 2012, pp. P10-11).

The controversial debate regarding the safety of vaccinations continues to captivate the masses; however we must understand whether the side effects from the vaccine outweigh the risk of the disease it may prevent. There is only one way to prevent the disease cervical cancer, and that is through examination, not vaccination. The vaccination available to aid in prevention of cervical cancer has some effectiveness and in many cases ineffectiveness, in preventing Human Papillomavirus. In essence, the most reliable method of prevention is regular visits with your physician.

The study was a secondary data analysis of existing patient records (record-based). This study made use of the National Inpatient Sample (NIS) Database .The NIS database was developed by the Healthcare Cost and Utilization Project (HCUP). The NIS is the largest inpatient care database in the United States containing data from 1988 to 2013. It includes about 98 percent of all hospital discharges in the United States. NIS is a sample of hospitals that comprises approximately 95 percent of all hospital discharges in the United States. It consists of over hundred nonclinical and clinical data elements for each hospital stay. The four most recent available calendar years (2010 to 2013) were obtained for the analyses of cervical cancer mortality

Approximately 500,000 new cases of cervical cancer occur each year worldwide, 260,000 of which are fatal. In the U.S., it is estimated that there were over 9,700 cases of cervical cancer in 2006, and of these 3,700 resulted in deaths”. Vaccinations are one of the most successful public health approaches to preventing and controlling infectious diseases. According to the CDC Advisory Committee on Immunization Practices the vaccine has been proven to be virtually 100% effective against the two types of HPV that are responsible for some 70% of cervical cancers.

Cervical cancer is one of the highly popular disease for the women. Different programmes has been made up to fight against this deadly disease. New Zealand has one of the best screening programmes in the world. The establishment of National Cervical Cancer Screening Programme in NZ in 1990 had reduced a significant number of 60% of women who develop cervical cancer and who die from it since it was built. More than 1 million New Zealander women are enrolled in this programme and 95 % are eligible. The Cervical Cancer screening programme aims to; informing women about the importance of having the cervical screening tests; promoting cervical screening tests on a regular basis to women aged 20–70; ensuring high-quality and culturally appropriate services; supporting women with abnormal tests; ensuring there is regular monitoring to see that the goals of the programme are being met. The NCSP also acknowledges the importance of the Treaty of Waitangi in providing a screening programme that is successful for all New Zealand women.

As many as 1,400 women in Canada are diagnosed with cancer of the cervix each year. More than 400 die from it (Mah et al, 2011).

Although there are several known risk factors for getting cervical cancer, no one knows exactly why one woman gets it and another doesn't. One of the most important risk factors for cervical cancer is infection with a virus called HPV (human papillomavirus). HPV is a sexually transmitted disease that is incredibly common in the population, one study showed that 43% of college age women were infected in a 3-year period. HPV is the virus that causes genital warts, but having genital warts doesn't necessarily mean you are going to get cervical cancer. There are different subtypes, or strains, of HPV. Only certain subtypes are likely to cause cervical cancer, and the subtypes that cause warts are unlikely to cause a cancer. Often, infection with HPV causes no symptoms at all, until a woman develops a pre-cancerous lesion mostly of the cervix. Because infection with a STD is a risk factor for cervical cancer, any risk factors for developing STD are also risk factors for developing cervical cancer. Women who have had many or several male sexual partners, having sexual intercourse at an early age, or have had male sexual partners who are considered high risk (meaning that they have had several sexual partners and/or began having sexual intercourse at an early age) are at higher risks for developing Cervical

In the United States, it is one of the eight-most common cancer of women. According to researches, the data shows that Hispanic women are significantly more likely to be diagnosed with cervical cancer than the general population and their median age at diagnosis is 48. In 1998, about 12,800 women were diagnosed in the US and about 4,800 died. Among cancers of the female reproductive tract, it is less common than endometrial cancer and ovarian cancer. The rates of new cases in the United States was 7 per 100,000 women in 2004. Cervical cancer deaths decreased by approximately 74% in the

SYSTEMATIC REVIEW OF HISTORICAL EPIDEMIOLOGICAL STUDY TRENDS IN ESTABLISHING THE CAUSAL RELATIONSHIP BETWEEN HPV AND CERVICAL CANCER: